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Abstract
Infection of human cells with the paramyxovirus simian virus 5 (SV5) results in minimal cytopathic effect, and host interferon (IFN) and
apoptotic pathways are not activated. We have previously shown that an rSV5 containing six naturally occurring P/V gene substitutions
(rSV5-P/V-CPI) displays premature and elevated expression of viral RNA and protein. In addition, cells infected with rSV5-P/V-CPI
show induction of the IFN- promoter as well as activation of IFN signaling and apoptotic pathways. In this article, we have tested the
hypothesis that rSV5-WT can supply trans-acting factors that prevent host cell antiviral responses induced by rSV5-P/V-CPI. During
coinfection of human A549 cells, rSV5-WT blocked cell rounding, loss of cell volume, and DNA fragmentation induced by rSV5-P/V-
CPI, three later events in the apoptotic pathway, but was not able to block the loss of mitochondrial membrane potential (m), an early
event in the cell death process. As expected, IFN signaling was blocked during coinfections, and this was attributed to the loss of STAT1
induced by the rSV5-WT V protein. Surprisingly, simultaneous infection with rSV5-WT could not suppress the activation of the IFN-
promoter by rSV5-P/V-CPI infection. However, the IFN- promoter was not activated in cells that were first preinfected for 1 h with
rSV5-WT and then subsequently infected with rSV5-P/V-CPI. A model is proposed for activation of host responses to infection with the
rSV5-P/V-CPI mutant and the steps that are blocked by rSV5-WT.
© 2003 Elsevier Inc. All rights reserved.
Introduction
Host antiviral responses can be important determinants
of pathogenesis, tropism, and activation of the adaptive
immune response (Roulston et al., 1999; Barber, 2001).
These responses include induction of cytokines and cell
death. During virus infection, the action of alpha/beta-inter-
feron (IFN/) is considered to be the most important arm
of the innate immune response (reviewed in Biron and Sen,
2001; Stark et al., 1998). Many of the identified IFN-in-
duced gene products have potent antiviral activity and can
contribute to the inhibition of host and viral protein synthe-
sis, induction of apoptosis, and clearance of viral infections.
As such, viruses have evolved mechanisms that counteract
the induction of IFN, the activation of the IFN signaling
pathways, and activation of apoptosis (reviewed in Garcia-
Sastre, 2001; Goodbourn et al., 2000; Barber, 2001; Roul-
ston et al., 1999). Paramyxoviruses are no exception to this
phenomenon and have been found to inhibit IFN synthesis
and/or signaling as well as apoptosis in a variety of ways
(Garcia-Sastre, 2001; Goodbourn et al., 2000; Young et al.,
2000; Iseni et al., 2002).
Many of these mechanisms for counteracting host re-
sponses have been attributed to the paramyxovirus P/V (and
sometimes C) gene (Didcock et al., 1999b; Garcin et al.,
1999, 2000; Kawano et al., 2001; Kubota et al., 2001;
Parisien et al., 2001; Takeuchi et al., 2001). Transcription of
the paramyxovirus P/V gene differs from transcription of
other viral genes, since the viral polymerase produces two
mRNAs from one gene by a process termed RNA editing
(Thomas et al., 1988). For SV5, accurate transcription of the
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P/V gene produces an mRNA that encodes the V protein,
while the P mRNA contains two additional nontemplate G
residues added cotranscriptionally by the viral polymerase
at a precise location in the P/V transcript (Thomas et al.,
1988). Thus, the V and P proteins share the same amino-
terminal segment (the P/V region) but have different C-
terminal regions. Previous results have shown that infection
of human cells with SV5 results in the loss of STAT1
protein, an essential component of the type I IFN signaling
pathway (Didcock et al., 1999a; Young et al., 2000). Trans-
fection experiments and expression of the SV5 V protein
from heterologous vectors have shown that V is sufficient to
inhibit IFN signaling in human cells by targeting STAT1 for
degradation by the proteasome (Didcock et al., 1999b).
Naturally occurring strains of SV5 have been isolated
that differ in their ability to block IFN signaling (Chatzian-
dreou et al., 2002). Canine parainfluenza virus-plus (CPI)
is an SV5 strain isolated from a dog with neurological
dysfunction (Baumgartner et al., 1981). CPI was subse-
quently isolated from a dog experimentally infected with
CPI (Baumgartner et al., 1991). Recent work has shown
that while infection with rSV5-WT induces STAT1 degra-
dation and blocks type I IFN signaling, the CPI strain is
defective in these two virus-induced alterations to the host
cell (Chatziandreou et al., 2002). Sequence analysis has
shown six amino acid differences in the amino-terminal
region of the P/V genes of CPI, which does not induce
STAT1 degradation, and the W3 (WT) strain of SV5, which
induces loss of STAT1 (Chatziandreou et al., 2002; South-
ern et al., 1991).
We and others have demonstrated that rSV5-WT is a
poor inducer of type I IFN, and that mutations in the P/V
gene can create an rSV5 that induces IFN (Wansley and
Parks, 2002; He et al., 2002). Recent evidence from trans-
fection experiments suggests that in addition to blocking
IFN signaling, the V protein is also capable of blocking IFN
synthesis induced by dsRNA (Poole et al., 2002). The CPI
virus is also a poor inducer of IFN, and transfection exper-
iments have shown that CPI V is as potent as rSV5-WT V
in blocking dsRNA-induced IFN synthesis (Poole et al.,
2002).
In our previous work, we created a virus in which the
N-terminal region of the P/V gene from rSV5-WT was
replaced with the same region of the CPI virus, introduc-
ing six amino acid changes into the genome of the virus
(Wansley and Parks, 2002). As expected, the rSV5-P/V-
CPI virus did not induce the degradation of STAT1 or the
subsequent block in ISRE signaling due to the P/V muta-
tions. Unexpectedly, this virus displayed several additional
phenotypes that differed from rSV5-WT. We found that
infection with rSV5-P/V-CPI resulted in premature and
elevated levels of viral RNA and protein as compared
to rSV5-WT. In addition, we demonstrated that while
rSV5-WT is a poor inducer of the IFN- promoter, infection
with rSV5-P/V-CPI results in activation of this promoter
and secretion of antiviral cytokines (Wansley and Parks,
2002; Young and Parks, 2003). Finally, while wild-type
SV5 is noncytopathic in most cell types (Choppin, 1964; He
et al., 2001; Parks et al., 2002), infection with rSV5-P/V-
CPI was found to induce severe cytopathic effect with
characteristics of apoptosis in multiple cell lines (Wansley
and Parks, 2002). Thus, when expressed in the context of
the WT rSV5 genome (Wansley and Parks, 2002), the CPI
V protein behaves differently than when expressed by trans-
fection (Poole et al., 2002).
In the present study, we have tested the hypothesis that
rSV5-WT can supply trans-acting factors that prevent in-
duction of host cell antiviral responses by rSV5-P/V-CPI.
Previous work on noncytopathic (ncp) and cytopathic (cp)
strains of hepatitis A virus (HAV) and bovine viral diarrhea
virus (BVDV) have used the approach of coinfecting cells
to determine if the ncp strain could block host cell responses
induced by the cp strain (Baigent et al., 2002; Brack et al.,
2002). Likewise, previous coinfection experiments have
shown that rSV5-WT can block apoptosis induced by an
rSV5 containing a deletion in the SH protein (rSV5-SH)
(He et al., 2001). In this article, we present a model for the
steps in host cell responses to rSV5-P/V-CPI infection
and use coinfections to show that rSV5-WT can block three
of the new phenotypes seen with rSV5-P/V-CPI.
Results
The cytopathic effect of infection with rSV5-P/V-CPI is
greatly reduced by coinfection with rSV5-WT
SV5 infection of most cell types results in minimal
cytopathic effect (CPE) (Choppin, 1964; He et al., 2001;
Parks et al., 2002). By contrast, we have previously discov-
ered that infection with rSV5-P/V-CPI results in extensive
CPE and infected cells die by a mechanism displaying
characteristics of apoptosis (Wansley and Parks, 2002). To
determine whether infection with rSV5-WT could block
induction of cell death by rSV5-P/V-CPI, A549 cells were
infected with rSV5-WT or rSV5-P/V-CPI at an m.o.i. of
5, or coinfected with both viruses as indicated in Fig. 1. At
48 h pi, a fluorescence-based TUNEL assay for DNA frag-
mentation was performed, and the number of TUNEL-
positive cells was quantitated as a percentage of total cells
in each field. As seen in Fig. 1, 30–35% of the cells were
TUNEL positive when infected with rSV5-P/V-CPI alone
at an m.o.i. of 5, consistent with our previous results (Wans-
ley and Parks, 2002). Less than 1% of cells infected with
rSV5-WT were TUNEL-positive (Fig. 1), similar to that
seen with mock-infected cells (not shown). During coinfec-
tion at an equal m.o.i. of 5, the percentage of TUNEL-
positive cells dropped to10% and continued to drop as the
m.o.i. of rSV5-WT infection increased. Background levels
of TUNEL staining were seen when cells were infected with
rSV5-WT and rSV5-P/V-CPI at m.o.i.s of 50 and 5,
respectively. These data support the hypothesis that during
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coinfection, rSV5-WT can block the cell death phenotype
induced by infection with rSV5-P/V-CPI.
The results in Fig. 1 could have been due to an ability of
rSV5-WT to exclude infection by rSV5-P/V-CPI. The
rSV5-P/V-CPI mutant had been constructed to contain a
gene for the green fluorescence protein inserted between the
HN and L genes, allowing it to be distinguished from
rSV5-WT (He et al., 1997; Wansley and Parks, 2002). To
determine whether rSV5-WT excluded rSV5-P/V-CPI
during coinfection, A549 cells were mock infected or in-
fected with rSV5-WT or rSV5-P/V-CPI alone at an m.o.i.
of 50, or coinfected with both viruses at an m.o.i. of 25 for
each virus, and then examined by fluorescence microscopy
at 24 h pi. As shown in Fig. 2, the majority of cells infected
with rSV5-P/V-CPI alone or coinfected with both viruses
were fluorescent above background levels seen during mock
and rSV5-WT infection. These results indicate that infec-
tion with rSV5-WT did not prevent coinfection with rSV5-
P/V-CPI. In a converse experiment, we also determined
that rSV5-P/V-CPI did not prevent coinfection with a
rSV5-WT expressing ovalbumin (rSV5-OVA) (Parks and
Alexander-Miller, 2002). Cells coinfected with rSV5-OVA
and rSV5-P/V-CPI were found to express both OVA and
GFP by immunofluorescence assays (Fig. 3A). It is note-
worthy that the micrographs shown in Fig. 2 also demon-
strate that during infection with rSV5-P/V-CPI many of
the cells had undergone morphological changes associated
with cell death such as cell rounding (Fig. 2, arrows), while
during coinfection with rSV5-WT and rSV5-P/V-CPI
there were fewer cells that were undergoing cell rounding.
Together with Fig. 1, the data in Fig. 2 demonstrate that
rSV5-WT can block elements of the cell death pathway
induced by rSV5-P/V-CPI, including cell rounding and
DNA fragmentation.
The reduced cytopathic effect seen during coinfection
with rSV5-P/V-CPI and rSV5-WT could be explained by
rSV5-WT reducing levels of gene expression from rSV5-P/
V-CPI. To test this hypothesis, A549 cells were mock
infected or infected with rSV5-OVA or rSV5-P/V-CPI
individually, or coinfected with both viruses at an m.o.i. of
5. At 12 h pi, cells were pulse radiolabeled with 35S -amino
acids, and proteins were immunoprecipitated from cell ex-
tracts with antibodies to the OVA protein to detect protein
synthesis from rSV5-OVA or with antibodies to GFP to
detect protein synthesis from rSV5-P/V-CPI. As seen in
Fig. 3B, the rate of protein synthesis of rSV5-OVA was
slightly reduced during coinfection as compared to infection
with rSV5-OVA alone (compare lanes 4 and 2, respectively,
left panel of figure). By contrast, the rate of protein synthe-
sis of rSV5-P/V-CPI-derived protein did not change dur-
ing coinfection with rSV5-OVA (compare lanes 3 and 4).
The data in Fig. 3 demonstrate that cells can be simulta-
neously infected by both rSV5-WT and rSV5-P/V-CPI,
and that the decreased cytopathic effect seen in coinfected
cells (Figs. 1 and 2) cannot be accounted for by reduced
levels of gene expression from rSV5-P/V-CPI.
During coinfection, rSV5-WT cannot block the loss of
mitochondrial membrane potential induced by
rSV5-P/V-CPI
DNA fragmentation detected by TUNEL staining is a
relatively late event in apoptotic cell death, occurring after
the activation of caspase-3 (Liu et al., 1997). To determine
if infection with rSV5-WT blocked an earlier stage of cell
death induced by rSV5-P/V-CPI, we measured changes in
mitochondrial membrane potential induced during SV5 in-
fection. Mitochondrial membrane permeabilization (MMP)
is an important early event in most apoptotic pathways,
which serves to initiate downstream events and results in
apoptotic death (Susin et al., 1996 and references therein).
This permeabilization results in the disruption of the inner
mitochondrial membrane potential (m) and is thought to
precede the fragmentation of DNA during apoptosis (Susin
et al., 1996 and references therein). Changes in mitochon-
drial membrane potential during SV5 infection were as-
sayed by flow cytometry using a cationic lipophilic fluoro-
chrome, tetramethylrhodaminemethylester (TMRM), whose
accumulation in the mitochondrial matrix is driven by the
electrochemical gradient. Cells with a high m show
bright fluorescence, while loss of m reduces fluores-
cence. In addition, the size of cells was assayed as a mea-
sure of cell shrinkage, a late step in apoptosis (Gomez-
Angelats et al., 2000).
A549 cells were mock infected or infected alone with
rSV5-WT or rSV5-P/V-CPI at an m.o.i. of 50 or coin-
fected at an m.o.i. of 25 for each virus. At 1, 15, and 30 h
pi, cells were harvested and analyzed by flow cytometry for
Fig. 1. TUNEL staining for cell death during coinfection. A549 cells were
infected at an m.o.i. of 5 for each individual virus, or coinfected with
rSV5-WT or rSV5-P/V-CPI at the indicated m.o.i. At 48h pi, TUNEL
staining was performed as described under Materials and methods. Ran-
dom fields of cells were observed and the number of TUNEL-positive cells
in each field was counted and calculated as the percentage of total cells in
the field. Mock infected samples showed only 1% TUNEL positive
staining (data not shown). Data are the average of three independent
experiments.
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TMRM staining. A representative of three independent ex-
periments is shown in Fig. 4, where the y-axis displays the
level of TMRM staining as a measure of m, while the
x-axis displays forward scatter as a measure of the size of
cells. Healthy cells are found in the upper right quadrant
with high m and normal size. Cells that have dropped
into the lower right quadrant have lost membrane potential
but are still of normal size, so they have not yet entered the
later stage of apoptosis (reviewed in Gomez-Angelats et al.,
2000). Cells that are found in the lower left quadrant have
lost membrane potential and have shrunk, identifying them
as a population that are in the late stages of cell death or are
already dead. As expected, 98% of mock-infected cells
were detected in the upper right quadrant at all time points
examined (Fig. 4). During rSV5-WT infection, 20% of
cells showed a small decrease in m by 30 h pi (lower
right quadrant). However, less than 1% of cells had addi-
tionally lost cell volume (lower left quadrant), consistent
with the lack of TUNEL staining in rSV5-WT-infected cells
(Fig. 1) (Wansley and Parks, 2002).
During infection with rSV5-P/V-CPI, by 30 h pi a
significant fraction of cells showed a large decrease in m
Fig. 2. Fluorescence microscopy of A549 cells coinfected with rSV5-WT and rSV5-P/V-CPI. A549 cells were mock infected (top), infected with rSV5-WT
(second row), or rSV5-P/V-CPI (third row) at an m.o.i. of 50, or coinfected at an m.o.i. of 25 for each virus (bottom). At 48 h pi, cells were analyzed for
expression of GFP by fluorescence microscopy. Phase contrast and GFP fluorescence for each sample are represented in the left and right columns,
respectively. Arrows indicate rSV5-P/V-CPI infected cells that have rounded up and show signs of later stages of apoptosis.
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Fig. 3. Viral protein expression in cells coinfected with rSV5-OVA and rSV5-P/V-CPI. (A) Immunofluorescence. A549 cells were mock infected (top),
infected with rSV5-OVA (second row) or rSV5-P/V-CPI (third row) at an m.o.i. of 5, or coinfected at an m.o.i. of 5 for each virus (bottom). At 48 h pi,
cells were permeabilized and analyzed for expression of GFP (middle column) or ovalbumin (OVA; right column) by fluorescence microscopy and
immunofluorescence, respectively. DAPI staining showed cells in each field (left column). (B) Rate of protein synthesis. A549 cells were mock infected (lane
1) or infected with rSV5-OVA (lane 2) or rSV5-P/V-CPI (lane 3) at an m.o.i. of 5 for each virus, or coinfected with rSV5-OVA and rSV5-P/V-CPI at
an m.o.i. of 5 for each virus (lane 4). At 12 h pi, cells were radiolabeled for 15 min using Tran[35S]-label and proteins were immunoprecipitated from cells
extracts using antibodies to GFP or OVA before analysis by SDS–PAGE.
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but not cell volume (32%, lower right quadrant), while 17%
have lost membrane potential and cell volume (lower left
quadrant), suggesting these cells had undergone cell death.
Surprisingly, during coinfection with rSV5-WT and rSV5-
P/V-CPI,45% of the cells showed some loss of m by
30 h pi (combined lower right and left quadrants), suggest-
ing that rSV5-WT was not able to block the loss of mem-
brane potential induced by rSV5-P/V-CPI. Importantly,
however, only 5% of cells that were coinfected with
rSV5-WT and rSV5-P/V-CPI had additionally lost cell
volume, as compared to 17% of rSV5-P/V-CPI-infected
cells. The observation that infection with rSV5-WT reduces
late-stage cell shrinkage is consistent with the data pre-
sented in Figs. 1 and 2 above showing that during coinfec-
tion, rSV5-WT can block cell rounding and DNA fragmen-
tation induced by rSV5-P/V-CPI. Taken together, these
data indicate that while rSV5-WT can block steps associ-
ated with the later phase of apoptotic cell death (cell round-
ing, cell shrinkage, DNA fragmentation), it is not as effec-
tive at blocking the early initiation steps of cell death (loss
Fig. 4. Loss of mitochondrial membrane potential during coinfection. A549 cells were mock infected or infected with rSV5-WT or rSV5-P/V-CPI at an
m.o.i. of 50, or coinfected at an m.o.i. of 25 for each virus. At 15 and 30 h pi, cells were harvested and processed for flow cytometry using TMRM as a
measure of m (y-axis) and forward scatter as a measure of cell size (x-axis). Data are representative of four independent experiments.
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of mitochondrial membrane potential) induced by infection
with rSV5-P/V-CPI.
Infection with rSV5-WT can block ISRE signaling induced
by rSV5-P/V-CPI infection
Infection with wild-type SV5 has been shown to block
the IFN-/ signaling pathway by inducing the proteasomal
degradation of STAT1 (Didcock et al., 1999b). In contrast,
we have shown that infection with rSV5-P/V-CPI does
not induce degradation of STAT1 and results in an activa-
tion of the IFN signaling pathway as assayed by transfection
of a plasmid containing the interferon-sensitive response
element (ISRE) (Wansley and Parks, 2002). To determine if
rSV5-WT could supply trans-acting factors that suppress
IFN signaling induced by rSV5-P/V-CPI infection, A549
cells were cotransfected with a plasmid containing the ISRE
upstream of a luciferase reporter gene and the pSV-gal
plasmid to normalize for transfection efficiency. Twenty-
four hours posttransfection, cells were infected with
rSV5-WT or rSV5-P/V-CPI alone or coinfected at various
m.o.i.s as shown in Fig. 5A. Sixteen hours postinfection,
cells were incubated with or without 2000 IU type I IFN to
induce the ISRE-luciferase gene, and 6 h later cells were
harvested and tested for induction of luciferase activity. As
shown in Fig. 5A, infection with rSV5-WT did not induce
the ISRE over levels observed in mock-infected cells, even
with exogenous IFN added, consistent with previous results
(Young et al., 2000). In contrast, infection with rSV5-P/V-
CPI induced ISRE activity with or without the addition of
exogenous IFN (Wansley and Parks, 2002). When cells
were coinfected with rSV5-WT and rSV5-P/V-CPI, there
was a progressive decrease in ISRE activity in cells infected
with increasing amounts of rSV5-WT. Importantly, when
equal amounts of each virus are added, the levels of ISRE
induction were reduced to levels similar to that of rSV5-WT
infection alone. This suppression of ISRE induction oc-
curred in both the presence and the absence of IFN.
Cell lysates from the experiment in Fig. 5A were ana-
lyzed by Western blotting to determine the levels of STAT1
in A549 cells coinfected with rSV5-WT and rSV5-P/V-CPI.
As seen in Fig. 5B, STAT1 was degraded in cells infected
with rSV5-WT, and upregulated in rSV5-P/V-CPI-in-
fected cells. This increase in STAT1 expression is thought
Fig. 5. IFN signaling and STAT1 degradation in cells coinfected with rSV5-V-CPI. (A) Induction of ISRE. A549 cells were cotransfected with pSV-gal
and a plasmid containing the luciferase gene under control of an ISRE. Twenty-four hours later, cells were mock infected or infected individually or together
with rSV5-WT and rSV5-P/V-CPI at the indicated m.o.i.s. At 16 h pi, cells were incubated for 6 h with (hatched bars) or without (white bars) 2000 units
of type I IFN. Normalized luciferase activity was calculated by dividing luciferase activity by -gal activity and is expressed as a fold induction over that
seen in mock-infected cells. Data are representative of three independent experiments. (B) STAT1 degradation during coinfection. A549 cells were infected
as described in (A). After treatment with or without IFN for 6 h, cells were lysed and equivalent amounts of protein analyzed by Western blotting with antisera
specific for the cellular STAT1 protein.
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to be because of the induction of IFN by this virus (Wansley
and Parks, 2002). As the m.o.i. of rSV5-WT was increased
during coinfection with rSV5-P/V-CPI, there was a dose-
dependent loss of STAT1 with levels of STAT1 similar to
that seen with rSV5-WT alone when equal m.o.i.s were
used. Taken together, these data indicate that during coin-
fection, the rSV5-WT phenotype of STAT1 degradation is
dominant over that of rSV5-P/V-CPI, and this loss of
STAT1 prevents activation of ISRE.
Coinfection with rSV5-WT does not block activation of
the IFN- promoter by rSV5-P/V-CPI infection
The original hypothesis to be tested was that rSV5-WT
could supply trans-acting factors that suppress IFN and cell
death induced by rSV5-P/V-CPI. To determine whether
rSV5-WT could block the induction of IFN synthesis by
rSV5-P/V-CPI, A549 cells were cotransfected with a plas-
mid containing the IFN- promoter (plux), and the pSV-
gal plasmid for normalizing transfection efficiencies.
Twenty-four hours posttransfection, cells were coinfected
such that the m.o.i. of rSV5-P/V-CPI infection was kept
constant at 5 and increasing amounts of rSV5-WT were
coinfected with rSV5-P/V-CPI. Sixteen hours postinfec-
tion, cells were lysed and luciferase activity was measured.
As expected, there was no detectable increase in luciferase
activity over mock infection when cells were infected with
rSV5-WT alone. As seen in Fig. 6, infection with rSV5-P/
V-CPI alone results in 6.2-fold induction of the plux
plasmid over mock-infected cells, as previously seen
(Wansley and Parks, 2002). Surprisingly, this level of in-
duction by rSV5-P/V-CPI infection was not affected by
increasing amounts of rSV5-WT added during coinfection.
The induction of the IFN- promoter was dependent on
gene expression from rSV5-P/V-CPI. This was shown by
UV inactivation of rSV5-P/V-CPI (Fig. 7). A549 cells
were cotransfected with the pSV-gal and plux plasmids
and then infected with ultraviolet (UV)-treated virus and
tested for induction of the IFN- promoter by luciferase
assay. As expected, there was no luciferase activity ob-
served in control or UV-treated mock- or rSV5-GFP-in-
fected cells (Fig. 7). Infection with rSV5-P/V-CPI re-
sulted in induction of the IFN- promoter, but when the
virus was inactivated before being added to cells, induction
of luciferase activity was abolished. These results indicate
that while the activation of the IFN- promoter by infection
with rSV5-P/V-CPI is dependent on viral gene expres-
sion, it cannot be blocked by coinfection with rSV5-WT.
Prior infection with rSV5-WT prevents activation of the
IFN- promoter by infection with rSV5-P/V-CPI
All of the data presented in this article thus far suggest
that during coinfection the phenotypes displayed during
rSV5-WT infection are dominant over the phenotypes seen
with rSV5-P/V-CPI infection, with the exception of in-
duction of the IFN- promoter. One possible explanation
for the result seen with the IFN- promoter is that since
infection with rSV5-P/V-CPI results in earlier and higher
than wild-type levels of protein and RNA expression
(Wansley and Parks, 2002), activation of the IFN- pro-
moter is dominant in coinfections with rSV5-WT because
rSV5-P/V-CPI proteins are made earlier and in more
abundance. In this hypothesis, an inducer of IFN (such as
dsRNA) would be made early during coinfection, before the
virus can establish mechanisms to counteract the host anti-
viral response. To test this hypothesis, we determined if
prior infection with rSV5-WT would prevent the activation
of the IFN- promoter by infection with rSV5-P/V-CPI.
A timeline for the experimental design is shown in Fig. 8.
Fig. 6. Induction of plux plasmid during coinfection. A549 cells were
cotransfected with a plasmid containing a luciferase gene under control of
the IFN- promoter and a pSV-gal plasmid to normalize for transfection
efficiency. Twenty-four hours posttransfection, cells were mock infected or
coinfected at a constant m.o.i. of 5 with rSV5-P/V-CPI, while rSV5-WT
was added in increasing amounts. Sixteen hours pi, cells were harvested
and normalized luciferase activity was calculated. Data are presented as the
average of three experiments.
Fig. 7. UV treatment reduces the ability of rSV5-P/V-CPI to induce the
IFN- promoter. A549 cells were transfected as described in the legend to
Fig. 6. Twenty-four hours posttransfection, cells were mock infected or
infected with rSV5-GFP and rSV5-P/V-CPI at an m.o.i. of 50 (striped
bars), or with virus that had been inactivated by UV treatment (solid bars).
Sixteen hours pi, cells were harvested and normalized luciferase activity
was measured. Data are presented as the average of three experiments.
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A549 cells were cotransfected with the plux and pSV-gal
plasmids, and 24 h later, infected with rSV5-WT at increas-
ing m.o.i.s from 0 to 50. One hour later, the same cells were
infected with rSV5-P/V-CPI at an m.o.i. of 50, and lucif-
erase activity was measured at 21 h after the initial infection
with wild-type virus. Fig. 8 demonstrates that as the m.o.i.
of prior infection with rSV5-WT increased, the level of
IFN- promoter activity induced by rSV5-P/V-CPI de-
creased until it reaches approximately that of rSV5-WT
alone when equal amounts of each virus are added. Prior
infection with rSV5-WT did not exclude subsequent infec-
tion with rSV5-P/V-CPI (data not shown). These data are
consistent with the hypothesis that the timing of infection
may play a role in the induction of IFN and that given only
a 1-h head start, rSV5-WT can effectively prevent the ac-
tivation of the IFN- promoter seen during infection with
by rSV5-P/V-CPI.
Discussion
In a previous study, we discovered that by introducing
six naturally occurring substitutions in the P/V gene of SV5
a number of phenotypes of the viral infectious cycle were
affected including the control of RNA expression, activa-
tion of IFN synthesis and signaling pathways, and a dra-
matic increase in cytopathic effect (Wansley and Parks,
2002). Fig. 9 illustrates a model for the induction of host
responses by infection with rSV5-P/V-CPI. In this model,
infection with rSV5-P/V-CPI results in production of a
viral inducer that leads to IFN- synthesis, IFN-signaling,
and expression of host antiviral genes (Fig. 9, left side).
Fig. 8. Prior infection with rSV5-WT prevents activation of the IFN- promoter by infection with rSV5-P/V-CPI. A549 cells were cotransfected with the
plasmids as described in the legend to Fig. 6, and 24 h later were mock infected, or infected with rSV5-WT at increasing m.o.i. as indicated. One hour pi,
cells were then mock infected or infected with rSV5-P/V-CPI. at an m.o.i. of 50. Sixteen hour pi, cells were harvested and luciferase activity was measured.
Normalized luciferase activity was calculated as described in Fig. 5. Data are presented as the average of three experiments.
Fig. 9. Model for the steps in IFN and apoptotic pathways that are blocked
by rSV5-WT during rSV5-P/V-CPI infection. Depicted in the diagram
are the events that occur during rSV5-P/V-CPI infection to activate IFN
and apoptotic pathways. Steps where rSV5-WT infection has been shown
to block this induction by rSV5-P/V-CPI are represented by (¢), while
steps where prior infection with rSV5-WT blocks induction by rSV5-P/V-
CPI infection are represented by an asterisk. Dotted line indicates a
possible pathway whereby IFN induced gene products activate apoptotic
pathways.
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Additionally, production of an inducer (which may be the
same or a different inducer than that seen with IFN) acti-
vates apoptotic pathways, resulting in cell death (Fig. 9,
right side). Based on the previous finding that rSV5-WT has
active mechanisms to prevent IFN synthesis (He et al.,
2002; Poole et al., 2002) as well as IFN signaling (Didcock
et al., 1999a,b), we have tested the hypothesis that the new
phenotypes seen in rSV5-P/V-CPI infections could be
corrected by coinfection with rSV5-WT. Our results indi-
cate that rSV5-WT possesses active mechanisms to prevent
three phenotypes shown in our model for rSV5-P/V-CPI
infection: induction of IFN synthesis, induction of IFN
signaling, and a late step in the apoptotic pathway.
In our previous study, we reported that while rSV5-WT
is noncytopathic for most cell types, infection with rSV5-
P/V-CPI resulted in rampant cell death by a pathway with
characteristics of apoptosis (Wansley and Parks, 2002).
These data suggested that rSV5-WT either does not synthe-
size an inducer of cell death to levels seen with rSV5-P/V-
CPI, or rSV5-WT has mechanisms to actively block the
induction of apoptosis, and these mechanisms are defective
for rSV5-P/V-CPI. We have found that during infection
with rSV5-WT, the majority of the cells retained their nor-
mal mitochondrial membrane potential, with a slight loss in
m in some infected cells. However, very few cells in the
population with a slight loss in m also showed late stages
of apoptosis (e.g., TUNEL staining, cell rounding, cell
shrinkage), indicating that rSV5-WT may have a mecha-
nism to block the induction of cell death at a later stage.
This proposal was supported by results from coinfection
experiments, where the induction of DNA fragmentation
and cell rounding but not loss of m by rSV5-P/V-CPI
was blocked by coinfection with rSV5-WT. Our results
indicate that rSV5-WT has active mechanisms to block the
induction of cell death pathways located downstream of the
loss of mitochondrial membrane potential, but before cell
rounding and the fragmentation of DNA. In addition to
being defective in blocking the late step in apoptosis, we
propose that rSV5-P/V-CPI makes more of the inducer of
cell death, as evidenced by the finding of more rSV5-P/V-
CPI-infected cells showing a significant loss of m.
Blocking the IFN signaling pathway is a common theme
seen with a number of paramyxoviruses, although there are
several different mechanisms used to accomplish the same
goal. For example, human parainfluenza virus type 2
(HPIV2) blocks this pathway by inducing the degradation of
STAT2 (Parisien et al., 2001), while Sendai virus (SeV) can
accomplish this by preventing the phosphorylation of
STAT1 (Takeuchi et al., 2001) or by changing the stability
of STAT1 (Garcin et al., 2003). While infection with
rSV5-WT results in a block in IFN signaling, we have
previously shown that infection with rSV5-P/V-CPI in-
duced ISRE signaling in the presence or absence of exog-
enous IFN (Young et al., 2000; Wansley and Parks, 2002).
In this study we show that during coinfection the wild-type
phenotype of blocking the induction of ISRE is dominant as
expected, since SV5 has a known active mechanism to
disrupt the IFN signaling pathway by V-mediated degrada-
tion of STAT1 (Didcock et al., 1999b). These data support
previous work using transfections of plasmids containing
the V protein of SV5 or CPI and shows that the ability to
target STAT1 degradation seen with plasmid-derived V can
be reproduced when expressed from the rSV5-WT genome.
/IFNs can induce apoptosis by activating the FADD/
caspase 8 pathway (Balachandran, et al., 2000). In addition,
previous results have shown that STAT1-null cell lines are
resistant to apoptosis induced by tumor necrosis factor-
(Kumar et al., 1997), suggesting that STAT1 can function in
the induction of apoptosis, possibly by activating ISRE
elements upstream of antiviral genes required for apoptosis.
Thus, SV5 actively blocks IFN signaling by targeting
STAT1 for degradation and this could indirectly result in a
block in activation of apoptosis. During rSV5-P/V-CPI
infection, /IFNs are synthesized (Wansley and Parks,
2002), and it is possible that this then activates cell death
pathways since STAT1 is not degraded by rSV5-P/V-CPI
infection. A similar model has been proposed during coin-
fection with ncp and cp strains of HAV. An ncp strain of
HAV can interfere with the ability of a cp strain to induce
cell death, and it is proposed that this is because the ncp
strain of HAV can inhibit the activation of IFN-induced
apoptosis (Brack et al., 2002). Together, our model (Fig. 9)
proposes that SV5 blocks cell death pathways by either
direct (e.g., by affecting activation of caspases; right side of
Fig. 9) or indirect methods (e.g., by blocking STAT1 in-
duction of antiviral genes) and does so at a stage after the
loss of m, but before the execution step involving DNA
fragmentation. Future work will focus on the mechanism of
the induction of cell death by rSV5-P/V-CPI and how
rSV5-WT blocks activation of apoptosis.
rSV5-WT is a very poor inducer of IFN- synthesis
(Didcock et al., 1999a; Poole et al., 2002; He et al., 2002;
Wansley and Parks, 2002). It is possible that the lack of IFN
production by infection with rSV5-WT could occur because
a viral protein acts to disable the host cell machinery that
senses viral infection. For example, the human papilloma-
virus E6 protein binds IRF-3 (Ronco et al., 1998), while the
influenza virus NS1 protein has been found to block the
phosphorylation of IRF-3 and thereby prevent translocation
to the nucleus (Talon et al., 2000). Previous data with SV5
has shown that the V protein prevents dsRNA-induced
translocation of IRF-3 to the nucleus (He et al., 2002). In the
case of rSV5-P/V-CPI infection, the activation of the
IFN- promoter could be occurring because rSV5-P/V-
CPI has lost the ability to disable the host sensing ma-
chinery, possibly because the CPI V protein in rSV5-P/
V-CPI is defective in blocking IRF-3 activation.
However, activation of IFN responses is likely to be more
complicated in the case of rSV5-P/V-CPI infections, since
the previous transfection experiments have shown that the
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wild-type SV5 V protein and CPI V protein are equally
potent at blocking activation of the IFN- promoter by
dsRNA (Poole et al., 2002). Therefore, the activation of the
IFN- promoter during rSV5-P/V-CPI infection cannot
be explained simply by the inability of the CPI V protein
to block induction of IFN- by dsRNA.
While dsRNA produced as a viral byproduct during
infection is often a potent inducer of IFN (Biron and Sen,
2001; Goodbourn et al., 2000), it is possible that dsRNA is
not primarily responsible for activating IFN pathways dur-
ing rSV5-P/V-CPI infection. In this regard, it has been
found that the N gene product of measles virus can activate
IRF-3 to induce IFN synthesis (tenOever et al., 2002). Thus,
it is possible that the NP protein of SV5 acts as an inducer
of IFN similar to that found with measles virus, and that the
interactions of NP with P or V (Randall and Bermingham,
1996) normally act to block the NP-induced IFN response in
cells infected with rSV5-WT. The hypothesis that dsRNA is
not the inducer of IFN during rSV5-P/V-CPI infection
could account for the discrepancy seen with blocking acti-
vation of the IFN- promoter with CPI V expressed alone
by transfection, and activation of the IFN- promoter when
CPI V is expressed in the context of other viral compo-
nents as seen during infection with rSV5-P/V-CPI. In
light of this discrepancy, it is important to emphasize that
the recombinant rSV5-P/V-CPI virus does not share all of
the properties seen with the native CPI virus, and it cannot
be assumed that the transfer of the CPI P/V mutations has
transferred all of the CPI phenotypes to WT rSV5.
The original CPI virus which was the source of the P/V
gene in rSV5-P/V-CPI is a poor inducer of IFN- (Poole
et al., 2002). In contrast, our results have shown that rSV5-
P/V-CPI (which has the same CPI P/V gene but on a
different genetic background) was a strong inducer of
IFN-, resulting in the induction of similar levels of IFN as
another known inducer of IFN, human parainfluenza virus
type 2 (5000–10,000 U/ml as compared to 5000–20,000
U/ml, respectively, Wansley and Parks, 2002). By making
the amino acid changes in the P/V gene with rSV5-P/V-
CPI, we may have abolished the ability of P or V to
interfere with NP induction of IFN. In this case, the NP gene
of CPI would be prevented from inducing IFN when
interacting with homologous CPI P and V proteins. Like-
wise, rSV5-WT NP could be prevented from inducing IFN
when interacting with homologous SV5 P and V proteins.
However, when rSV5-WT NP interacts with the heterolo-
gous P/V gene products of CPI, it could behave quite
differently.
If the CPI V protein can still function to block dsRNA-
induced IFN pathways, what then is the mechanism by
which rSV5-P/V-CPI induces IFN? The most striking
result from our studies is that rSV5-WT can block activation
of the IFN- promoter by rSV5-P/V-CPI only after prior
infection, but not during coinfection with both viruses. Sim-
ilar results have been found with HAV, where it has been
shown that preinfection with an ncp strain can reduce the
replication of a cp strain (Brack et al., 2002). It was hy-
pothesized that the ncp strain controls viral replication to
ensure that dsRNA does not accumulate to levels high
enough to overcome the block in IFN pathways. In this case,
there is a balance between allowing enough gene expression
necessary to inhibit the antiviral response early on, but not
allowing viral byproducts to accumulate to levels where this
inhibition could be overcome. We propose that a similar
mechanism is in place with rSV5-WT, where gene expres-
sion early after infection is controlled to avoid inducing the
antiviral response before inhibitory mechanisms are in
place. By contrast, rSV5-P/V-CPI has lost the early con-
trol mechanisms that prevent activation of IFN pathways.
Alternatively, it is possible that there is a limiting host factor
that is required for replication of rSV5-WT and rSV5-P/V-
CPI, and that during the prior infection with rSV5-WT,
this host factor is titrated away and is no longer available to
support the replication of rSV5-P/V-CPI, resulting in de-
creased viral gene expression from rSV5-P/V-CPI.
The SeV V protein is thought to interact with NP to
inhibit RNA replication by blocking NP encapsidation of
the genome (Horikami et al., 1992). Since the SV5 V pro-
tein binds to soluble but not polymeric NP (Randall and
Bermingham, 1996), it is possible that the CPIP/V sub-
stitutions decrease the ability of V to bind wild-type NP and
effectively inhibit replication during rSV5-P/V-CPI infec-
tion. Alternatively, the P/V mutations could increase the
activity of the P protein, resulting in accelerated RNA syn-
thesis due to a more active polymerase. In both of these
cases, wild-type SV5 regulates RNA synthesis early during
infection so as not to cross the threshold that activates the
IFN response, while rSV5-P/V-CPI has lost control of this
regulation of RNA synthesis, and the IFN synthesis path-
way is activated. It is important to note that the P and V
proteins of SV5 serve multiple functions in the viral life
cycle (Lamb and Kolakofsky, 2001), and it is not known
whether the mutations in rSV5-P/V-CPI affect the func-
tion of the P or the V protein. Therefore, we cannot attribute
the induction of IFN to either the P or the V proteins of
rSV5-P/V-CPI. Work is in progress to determine which of
these proteins are responsible for each phenotype seen with
rSV5-P/V-CPI infection.
In summary, we propose a model whereby rSV5-WT
components can act in trans to correct the induction of
apoptosis, IFN signaling, and the IFN- promoter that is
seen during infection with rSV5-P/V-CPI. In this model,
the P or V protein of rSV5-WT acts in trans to restrict an
inducer of IFN (e.g., the synthesis of dsRNA or the activity
of NP) to levels that will not trigger the induction of IFN. As
an additional level of control, rSV5-WT can actively block
the induction of IFN synthesis by inhibiting the transloca-
tion of IRF-3 to the nucleus (He et al., 2002) and IFN
signaling by degrading STAT1 (Didcock et al., 1999a),
blocking host cell factors involved in the antiviral response.
51E.K. Wansley et al. / Virology 316 (2003) 41–54
Either the same or additional viral inducers activate apopto-
tic pathways during rSV5-P/V-CPI but not rSV5-WT in-
fection. The degradation of STAT1 and block in IFN sig-
naling and/or synthesis may contribute to the lack of
cytopathic effect seen during rSV5-WT infection. Our data
are consistent with the hypothesis that rSV5-WT also pos-
sesses an active mechanism to block the induction of cell
death at a step after the loss of mitochondrial membrane
potential, but before the fragmentation of DNA. Work is in
progress to further elucidate the mechanisms by which
rSV5-WT prevents the activation of host antiviral re-
sponses, as well as what functions are defective in the case
of the rSV5-P/V-CPI mutant.
Materials and methods
Cells, viruses, and UV inactivation
Monolayer cultures of cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% fetal
bovine serum (FBS). W3A strain of SV5 was grown in
MDBK cells. rSV5-P/V-CPI was recovered from cDNA
and grown in Vero cells as described previously (Wansley
and Parks, 2002). rSV5-OVA was recovered from cDNA
and grown as described previously (Parks and Alexander-
Miller, 2002). For inactivation of virus by UV treatment,
viruses diluted in DMEM/10% BSA were held in 60-mm
dishes for 20 min under a handheld germicidal UV lamp at
a distance of 6.5 cm, and the resulting media was added to
A549 cells and subsequently treated as infected samples.
This procedure eliminated all infectivity as determined by
plaque assays.
Transfection of reporter plasmids and IFN protection
assays
Induction of the IFN- promoter was assayed using
plux, a plasmid containing the upstream 38–470 bases of
the murine IFN- regulatory region, including all four pos-
itive regulatory domains (PRDI to IV) linked to a luciferase
reporter gene (Noah et al., 1999). The pSV-gal plasmid
(Promega) consists of the -galactosidase gene under the
control of a constitutive SV40 promoter and was used to
normalize for transfection efficiencies between samples.
Transfection-infection experiments were performed in six-
well dishes of A549 cells as described previously using
FUGENE 6 (Wansley and Parks, 2002). Normalized lucif-
erase activity was calculated as luciferase activity divided
by -galactosidase activity. Expression from the pSV-gal
plasmid was not responsive to IFN stimulation.
A pISRE-luc plasmid containing five copies of the
ISG54 ISRE element upstream of a TATA box and lucif-
erase reporter gene (Parisien et al., 2001) was used to
measure induction of ISRE transcription. Transfection-in-
fection experiments using A549 cells were carried out as
described previously (Wansley and Parks, 2002). Sixteen
hours pi, cell media was supplemented for 6 h with or
without 2000 units human universal type I IFN (A/D, PBL
Biomedical Laboratories), as described (Young et al.,
2000). Cells were harvested in reporter lysis buffer and
normalized luciferase activity was calculated.
Western blotting, isotopic labeling of polypeptides, and
immunoprecipitation analysis
Six-well dishes of A549 cells were infected with WT
rSV5-GFP or rSV5-P/V-CPI as described in each figure
legend. Cell lysates were treated as described (Wansley and
Parks, 2002) and analyzed by Western blotting with rabbit
antisera to the cellular STAT1 protein (clone 554, Santa
Cruz Biotechnology) followed by HRP-conjugated second-
ary antibodies and ECL.
To detect radiolabeled proteins, A549 cells that were
mock infected, infected individually, or coinfected with
rSV5-GFP or rSV5-P/V-CPI were radiolabeled for 15 min
at 12 h pi using 200 Ci/ml Tran[35S]-label. Cells were
lysed in 1% SDS and proteins immunoprecipitated from cell
extracts using polyclonal antibodies to GFP (Invitrogen) or
ovalbumin (OVA) (Parks and Alexander-Miller, 2002) be-
fore analysis by SDS–PAGE as described (Wansley and
Parks, 2002).
Fluorescence microscopy assays
Microscopy experiments were performed as previously
described on a Nikon Eclipse fluorescence microscope us-
ing a 20 lens (Wansley and Parks, 2002). For apoptosis
assays, 3.5-cm dishes of A549 cells were mock infected or
infected with rSV5 viruses and fixed with a 3:1 mix of
ethanol:acetic acid for 10 min at RT. TUNEL staining was
performed as described by the In Situ Death Detection Kit
(Roche Molecular Biochemicals). For immunofluorescence
assays, six-well dishes of A549 cells were mock infected or
infected with rSV5-OVA (Parks and Alexander-Miller,
2002) or rSV5-P/V-CPI as described in the figure legends.
Cells were fixed and permeabilized with saponin before
incubating with rabbit antisera to ovalbumin followed by
rhodamine-conjugated goat anti-rabbit secondary antibodies
and observed by fluorescence microscopy. Subconfluent
monolayers were used to collect data on a per cell basis and
to avoid crowding of cells.
Flow cytometry analysis
Six-well dishes of cells were mock infected or infected
with rSV5-GFP or rSV5-P/V-CPI as described in each
figure legend. At each time p.i., both media and cells were
harvested and cells were treated as described previously
(Wansley and Parks, 2002). The GFP fluorescence of indi-
vidual cells was measured using a FACScalibur flow cy-
tometer (Becton Dickinson Biosciences). Loss of mitochon-
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drial membrane potential (m) was analyzed by TMRM
staining as described (Castedo et al., 2002).
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